Ongoing Pharmacological Developments in SLC6A1 Research & Treatment
Clin Pharmacol Ther
.
2024 Dec;116(6):1381-1384.
doi: 10.1002/cpt.3413.
Epub 2024 Aug 16.
Authors
Melissa B DeLeeuw
1
2
3
4
,
Jacob Tiller
5
6
,
Jing-Qiong Kang
1
3
4
,
Amber Freed
5
Affiliations
1
Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, Tennessee, USA.
2
Department of Biomedical Sciences, Meharry Medical College, Nashville, Tennessee, USA.
3
Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
4
Vanderbilt Brain Institute, Nashville, Tennessee, USA.
5
SLC6A1 Connect Organization, Dallas, Texas, USA.
6
Brown University, Providence, Rhode Island, USA.
PMID:
39150328
DOI:
10.1002/cpt.3413
No abstract available